请登录
搜索 英文站
栏目

提醒成功

请输入手机号/邮箱号
请输入密码

账号密码登录

微信/QQ登录 微信/QQ登录

没有账号? 立即注册

搜索
产品规范
Type In Vivo - Reseach Grade Antibody
Host CHO cells
catalog# B00055
Application Flow cytometry, animal model study
Size/Concentration 1mg/5mg/20mg
Isotype Human IgG1 kappa
Storage Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles.
Species Reactivity Human
Immunogen Human Trop-2
Formulation PBS, pH 7.4

Description

What is sacituzumab biosimilar research grade? Sacituzumab Biosimilar uses the same protein sequences as the therapeutic antibody sacituzumab. Sacituzumab govitecan is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate used for the treatment of metastatic triple-negative breast cancer and metastatic urothelial cancer. Triple-negative breast cancer is a type of breast cancer that tests negative for estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2 (HER2) protein. Therefore, triple-negative breast cancer does not respond to hormonal therapy medicines or medicines that target HER2. Sacituzumab govitecan is a conjugate of the humanized anti-Trop-2 monoclonal antibody linked with SN-38, the active metabolite of irinotecan. Each antibody having on average 7.6 molecules of SN-38 attached. SN-38 is too toxic to administer directly to patients, but linkage to an antibody allows the drug to specifically target cells containing Trop-2.

Sacituzumab Biosimilar, Trop-2 Monoclonal Antibody B00055

规格:

  • 1mg
  • 5mg
  • 20mg

数量:

-
+

说明书:

¥1300

¥1300
加入购物车
立即购买
Sacituzumab Biosimilar, Trop-2 Monoclonal Antibody-远泰生物
请登录
搜索 英文站
栏目

提醒成功

请输入手机号/邮箱号
请输入密码

账号密码登录

微信/QQ登录 微信/QQ登录

没有账号? 立即注册

搜索
产品规范
Type In Vivo - Reseach Grade Antibody
Host CHO cells
catalog# B00055
Application Flow cytometry, animal model study
Size/Concentration 1mg/5mg/20mg
Isotype Human IgG1 kappa
Storage Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles.
Species Reactivity Human
Immunogen Human Trop-2
Formulation PBS, pH 7.4

Description

What is sacituzumab biosimilar research grade? Sacituzumab Biosimilar uses the same protein sequences as the therapeutic antibody sacituzumab. Sacituzumab govitecan is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate used for the treatment of metastatic triple-negative breast cancer and metastatic urothelial cancer. Triple-negative breast cancer is a type of breast cancer that tests negative for estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2 (HER2) protein. Therefore, triple-negative breast cancer does not respond to hormonal therapy medicines or medicines that target HER2. Sacituzumab govitecan is a conjugate of the humanized anti-Trop-2 monoclonal antibody linked with SN-38, the active metabolite of irinotecan. Each antibody having on average 7.6 molecules of SN-38 attached. SN-38 is too toxic to administer directly to patients, but linkage to an antibody allows the drug to specifically target cells containing Trop-2.

Sacituzumab Biosimilar, Trop-2 Monoclonal Antibody B00055

规格:

  • 1mg
  • 5mg
  • 20mg

数量:

-
+

说明书:

¥1300

¥1300
加入购物车
立即购买